421
Participants
Start Date
October 21, 2014
Primary Completion Date
June 4, 2015
Study Completion Date
April 26, 2016
OnabotulinumtoxinA
OnabotulinumtoxinA injected into the protocol-specified areas. Subjects will receive at least 1 and up to 3 treatments.
Normal Saline
Placebo (normal saline) injected into the protocol-specified areas on Day 1.
Steven Fagien, MD, PA, Boca Raton
Total Skin and Beauty Dermatology Center, PC, Birmingham
Laser & Skin Surgery Center of Indiana, Carmel
Henry Ford Medical Center, West Bloomfield
Coleman Center For Cosmetic Dermatologic Surgery, Metairie
About Skin Dermatology and DermSurgery, PC, Greenwood Village
Advanced Research Associates, Glendale
Clinical Science Institute, Santa Monica
NW Dermatology and Research Center, Portland
Carruthers Dermatology Centre, Vancouver
Dr. Shannon Humphrey, Inc., Vancouver
Jean Carruthers Cosmetic Dermatology, Vancouver
Sweat Clinics of Canada, Toronto
Arthur Swift Research, Inc., Westmount
Aesthetic Surgery Ireland, Dublin
Beacon Face and Dermatology Clinic, Dublin
Lead Sponsor
Allergan
INDUSTRY